by irdadmin | Mar 14, 2017 | Financial Markets, Gold, Market Manipulation, Precious Metals, U.S. Economy
Valeant (VRX) stock is now at $10. After a brief, Roman Candle launch to $260, $10 is the level where it traded in early 2009. It may be one of the few stocks that has gone back its financial crisis trading level. It is now likely on a long, slow death march to zero....
by irdadmin | Apr 5, 2016 | Financial Markets
Valeant stock bounced today on the news that it had completed an internal review of its accounting issues with respect to revenue recognition and did not find any additional problems (Wall St Journal). Famous last words there…VRX announced that it intends to...
by irdadmin | Mar 18, 2016 | Financial Markets, Market Manipulation
A reader asked my opinion on the latest commentaries posted on Seeking Alpha about VRX. Generally they had a bullish slant, permeated with gratuitous rationalization seeded in blind hope. “Hope” is not a valid investment strategy. VRX is down another 8%...
by irdadmin | Mar 17, 2016 | Financial Markets
Valeant stock is down another 10% today. I’m wondering if some of the Wall Street Journal writers are reading this blog because the WSJ published an article late yesterday in which it reported that VRX could be forced to write-down its goodwill. I published an...
by irdadmin | Mar 15, 2016 | Financial Markets, Market Manipulation
Valeant Pharmaceuticals (VRX) stock has plunged 86% since August 6. The latest plunge occurred today, with the stock losing 51% from its close of $78 yesterday (click to enlarge): The initial triggers were concerns over the Valeant’s drug-pricing policies and...
